Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cobra Biologics Re-brands Recipharm Unit | Contract Pharma

What are you searching for?

Sign in
Breaking News

Cobra Biologics Re-brands Recipharm Unit

Offers integrated and stand-alone development services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Following Cobra Biologics’ acquisition of Recipharm AB’s biologics business in June, the business has been re-launched and re-branded under the name of Cobra Biologics. Cobra Biologics has two GMP approved facilities in Södertälje, Sweden (south of Stockholm) and Keele, UK, just south of Manchester.

Julian Hanak, commercial director of Cobra Biologics, said, “From both sites, our organization offers a broad range of integrated and stand-alone development services, stretching from cell line development through to the supply of investigational medicinal product, including regulatory support. We take pride in manufacturing excellence, delivering what we promise and helping our customers to develop drugs for the benefit of patients.”

Peter Coleman, chief executive officer of Cobra Biologics said, “As a newly independent organization, we are delighted to be rebranding with a name that resonates very strongly with the biopharmaceutical sector and which plays to our long established heritage and recognized expertise.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters